Eligibility criteria in phase 3 randomized controlled trials in metastatic non-small cell lung cancer. Borysowski J, Klosowska D, Harhala M, Knetki-Wroblewska M, et al. Cancer 2026;132:e70361.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Borysowski J, Klosowska D, Harhala M, Knetki-Wroblewska M, et al. Eligibility criteria in phase 3 randomized controlled trials in metastatic non-small cell lung cancer. Cancer 2026;132:e70361.
PMID: 41838447